Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
19.73
-0.26 (-1.30%)
At close: Mar 28, 2024, 4:00 PM
19.34
-0.39 (-1.98%)
After-hours: Mar 28, 2024, 6:26 PM EDT

Kiniksa Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
107.95122.72122.47114.2546.9372.1945.6656.08
Short-Term Investments
98.4267.8959.73209.44186.45235.3300
Cash & Cash Equivalents
206.37190.61182.2323.69233.38307.5145.6656.08
Cash Growth
8.27%4.61%-43.71%38.70%-24.11%573.49%-18.57%-
Receivables
21.2712.663.9900000
Inventory
31.1221.63.6800000
Other Current Assets
17.5418.196.599.568.256.241.440.26
Total Current Assets
276.3243.06196.45333.25241.63313.7547.156.33
Property, Plant & Equipment
12.677.048.3810.628.336.360.130.08
Long-Term Investments
00000.21000
Goodwill and Intangibles
17.2518.2519.2500000
Other Long-Term Assets
220.11191.328.725.64.371.860.260.05
Total Long-Term Assets
250.03216.6136.3516.2212.918.220.390.13
Total Assets
526.32459.67232.8349.46254.53321.9747.4956.47
Accounts Payable
8.257.91.870.55.6910.921.220.21
Deferred Revenue
12.2612000000
Current Debt
2.253.33.382.111.7000
Other Current Liabilities
40.9123.8739.5829.2420.4431.6416.212.09
Total Current Liabilities
63.6747.0744.8231.8527.8342.5517.432.3
Long-Term Debt
10.012.622.674.880.96000
Other Long-Term Liabilities
13.8113.840.270.810.330.1400
Total Long-Term Liabilities
23.8216.462.945.681.280.1400
Total Liabilities
87.4863.5247.7637.5329.1142.717.432.3
Total Debt
12.265.926.056.992.65000
Debt Growth
107.10%-2.17%-13.39%163.39%----
Retained Earnings
-477.95-492.03-675.4-517.47-356.09-194.23-91-26.13
Comprehensive Income
0.010.04-0.07-0.030.03-000
Shareholders' Equity
438.84396.15185.04311.94225.42279.27-89.71-25.73
Net Cash / Debt
194.11184.69176.15316.71230.73307.5145.6656.08
Net Cash / Debt Growth
5.10%4.85%-44.38%37.26%-24.97%573.49%-18.57%-
Net Cash Per Share
2.702.622.575.124.2710.4125.23214.28
Working Capital
212.63195.99151.62301.4213.8271.229.6754.03
Book Value Per Share
6.265.712.705.044.179.45-49.57-98.33
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).